Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, S. aureus can disseminate to infect almost any organ, but bones, joints and heart valves are most frequently affected. Despite the infection's severity, the...

Полное описание

Библиографические подробности
Главные авторы: Thwaites, G, Auckland, C, Barlow, G, Cunningham, R, Davies, G, Edgeworth, J, Greig, J, Hopkins, S, Jeyaratnam, D, Jenkins, N, Llewelyn, M, Meisner, S, Nsutebu, E, Planche, T, Read, R, Scarborough, M, Soares, M, Tilley, R, Török, M, Williams, J, Wilson, P, Wyllie, S, Walker, A
Формат: Journal article
Язык:English
Опубликовано: 2012

Схожие документы